Medline Inc (MDLN) Hedge Fund Ownership (Q2 2026)

Q: Is it too late to buy Medline Inc (MDLN) following the 2026 Q2 hedge fund 13F filings?

As of today, MDLN has moved -7.7% since the 2026 Q2 13F filing date (August 14, 2026), compared to -0.6% for the XLV sector ETF — an outperformance of -7.1%. Since the quarter end (June 30, 2026), MDLN gained -16.4% vs +10.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Medline Inc (MDLN)

400 + Investors. Track Smart Money conviction in MDLN. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — MDLN

Based on 403 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added MDLN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

403 hedge funds hold MDLN right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +40200% more funds vs a year ago

fund count last 6Q

+402 new funds entered over the past year (+40200% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 69% buying

328 buying145 selling

Last quarter: 328 funds were net buyers (176 opened a brand new position + 152 added to an existing one). Only 145 were sellers (64 trimmed + 81 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+24 vs last Q)

new funds entering per quarter

Funds opening a new MDLN position: 0 → 200 → 152 → 176. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

🔄

Mostly new holders — 97% entered in last year

■ 2% conviction (2yr+) ■ 1% medium ■ 97% new

Only 7 funds (2%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💎

Buying through price weakness — shares +22%, value +7%

Value

+6%

+22%

Last quarter: funds added +22% more shares while total portfolio value only changed +7%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

🚀

Acceleration phase — new buyers rushing in

0 → 0 → 200 → 152 → 176 new funds/Q

New funds entering each quarter: 0 → 200 → 152 → 176. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🌱

Early stage — 98% of holders entered in last year

■ 2% veterans ■ 0% 1-2yr ■ 98% new

Of 416 current holders: 409 (98%) entered in the past year, only 7 (2%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

✅

Strong quality — 37% AUM from major funds

37% from top-100 AUM funds

61 of 403 holders rank in the top 100 by AUM, accounting for 37% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

7.4

out of 10

High Exit Risk

Exit risk score 7.4/10 — multiple crowding signals converge. Institutional ownership is at 100% of its all-time high — near peak crowding. Crowded trades can unwind fast — a single catalyst can trigger a cascade.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	400	308	29.87%
13F Shares	755M	637M	18.4%
Total Value	$29.14B	$27.88B	4.5%
New Positions	174	152	+22
Increased Positions	147	104	+43
Closed Positions	82	45	+37
Reduced Positions	62	30	+32
Total Calls	6	6	-
Total Puts	7	7	-
PUT/CALL Ratio	1.17	1.17	Neutral

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

400

308

29.87%

13F Shares

755M

637M

18.4%

Total Value

$29.14B

$27.88B

4.5%

New Positions

174

152

+22

Increased Positions

147

104

+43

Closed Positions

+37

Reduced Positions

+32

Total Calls

Total Puts

PUT/CALL Ratio

1.17

Neutral

Institutional Holders (2026 Q2)

400 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in MDLN. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 MDLN holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	H&F Corporate Investors X, Ltd.	100.00%	70,874,326	$2.80B
2	Carlyle Group Inc.	73.78%	187,083,713	$7.38B
3	Mbb Public Markets I LLC	10.40%	2,441,379	$96.3M
4	SurgoCap Partners LP	9.55%	7,487,507	$295.3M
5	Khrom Capital Management LLC	8.05%	2,435,635	$96.1M
6	Egerton Capital (UK) LLP	6.28%	16,470,884	$649.6M
7	Seven Grand Managers, LLC	5.80%	3,651,044	$144.0M
8	Obion Capital Management LP	5.23%	156,000	$6.2M
9	Lone Pine Capital LLC	5.06%	20,968,367	$827.0M
10	Renaissance Capital LLC	4.98%	228,828	$9.0M
11	Clio Asset Management LLC	4.93%	157,171	$6.2M
12	PICTET BANK & TRUST Ltd	4.01%	94,900	$3.7M
13	Pelham Capital Ltd.	3.36%	149,598	$5.9M
14	Sagewood Asset Management LP	3.02%	338,196	$13.3M
15	Eminence Capital, LP	2.33%	2,279,190	$101.4M
16	Ghisallo Capital Management LLC	2.32%	3,000,000	$118.3M
17	Burkehill Global Management, LP	2.14%	1,500,000	$59.2M
18	Banque Pictet & Cie SA	1.81%	7,312,150	$288.4M
19	Fremen Capital Management LP	1.66%	47,833	$1.9M
20	Ravenswood Partners LP	1.46%	115,917	$4.6M
21	Unisphere Establishment	1.24%	3,682,500	$145.2M
22	Pacific Capital Partners Ltd	1.03%	30,273	$1.2M
23	Durable Capital Partners LP	1.01%	2,627,321	$103.6M
24	Port Capital LLC	0.93%	579,886	$22.9M
25	Quantessence Capital LLC	0.93%	7,984	$315K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Medline Inc (MDLN)

What does the Smart Money Trend signal show for MDLN?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added MDLN than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for MDLN?

More buyers than sellers — 69% buying: Last quarter: 328 funds were net buyers (176 opened a brand new position + 152 added to an existing one). Only 145 were sellers (64 trimmed + 81 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for MDLN holders?

Strong quality — 37% AUM from major funds: 61 of 403 holders rank in the top 100 by AUM, accounting for 37% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held MDLN?

Mostly new holders — 97% entered in last year: Only 7 funds (2%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Medline Inc (MDLN) following the 2026 Q2 hedge fund 13F filings?

As of today, MDLN has moved -7.7% since the 2026 Q2 13F filing date (August 14, 2026), compared to -0.6% for the XLV sector ETF — an outperformance of -7.1%. Since the quarter end (June 30, 2026), MDLN has gained -16.4% vs +10.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Medline Inc (MDLN)

Smart Money Signals — MDLN

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +40200% more funds vs a year ago

More buyers than sellers — 69% buying

More new buyers each quarter (+24 vs last Q)

Mostly new holders — 97% entered in last year

Buying through price weakness — shares +22%, value +7%

Acceleration phase — new buyers rushing in

Early stage — 98% of holders entered in last year

Strong quality — 37% AUM from major funds

Institutional Sentiment Summary — MDLN

Hedge Fund Ownership: MDLN

Market Analysis: MDLN

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: MDLN

Is It Too Late to Buy Medline Inc (MDLN) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: MDLN

Statistics: MDLN

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Medline Inc (MDLN)

Welcome to 13Foresight!